← Leaderboards
Farah Sheikh
University Of California, San Diego
$8,379,253
Attributed
$8,577,048
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,577,048 · 7
By mechanism
R01$8,160,849 · 4
R21$395,590 · 1
P41$20,609 · 2
Top collaborators
- Karen L Christman2 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Jason R Pellman$71,991
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsHeartCardiacDesmosomesMolecularCardiac MyocytesExhibitsIn VivoMouse ModelIntercellular JunctionsArrhythmogenic Right Ventricular DysplasiaIn VitroDesmoplakinGeneticPhysiologicalDefectMyocardiumMutationHeart DiseasesCardiomyopathiesConnexinsBaseProteinsAdult
Grant awards (25)
Understanding Early Drivers and Therapeutic Targets for Severe Forms of Arrhythmogenic Cardiomyopathy$727,710
R01 · FY2025 · HL · contact PI
Uncovering Molecular Targets for Arrhythmogenic Cardiomyopathy Therapeutics$395,000
R01 · FY2025 · HL · contact PI
Uncovering Molecular Targets for Arrhythmogenic Cardiomyopathy Therapeutics$395,000
R01 · FY2024 · HL · contact PI
Determinants of Arrhythmogenic Risk In Arrhythmogenic Cardiomyopathies and Mitral Valve Prolapse$395,000
R01 · FY2023 · HL · contact PI
Uncovering Molecular Targets for Arrhythmogenic Cardiomyopathy Therapeutics$395,000
R01 · FY2023 · HL · contact PI
Uncovering Molecular Targets for Arrhythmogenic Cardiomyopathy Therapeutics$395,000
R01 · FY2022 · HL · contact PI
Uncovering New Functions of CSN6 in Cardiac Desmosomal Biology and Disease$395,000
R01 · FY2021 · HL · contact PI
Uncovering New Functions of CSN6 in Cardiac Desmosomal Biology and Disease$393,854
R01 · FY2020 · HL · contact PI
Uncovering New Functions of CSN6 in Cardiac Desmosomal Biology and Disease$393,750
R01 · FY2019 · HL · contact PI
Uncovering New Functions of CSN6 in Cardiac Desmosomal Biology and Disease$392,604
R01 · FY2018 · HL · contact PI
The molecular mechanisms underlying arrhythmogenic right ventricular dysplasia/cardiomyopathy$387,500
R01 · FY2018 · HL · contact PI
The molecular mechanisms underlying arrhythmogenic right ventricular dysplasia/cardiomyopathy$387,500
R01 · FY2017 · HL · contact PI
The molecular mechanisms underlying arrhythmogenic right ventricular dysplasia/cardiomyopathy$387,500
R01 · FY2016 · HL · contact PI
The molecular mechanisms underlying arrhythmogenic right ventricular dysplasia/cardiomyopathy$387,500
R01 · FY2015 · HL · contact PI
The molecular mechanisms underlying arrhythmogenic right ventricular dysplasia/ca$418,576
R01 · FY2013 · HL · contact PI
The molecular mechanisms underlying arrhythmogenic right ventricular dysplasia/ca$439,375
R01 · FY2012 · HL · contact PI
The molecular mechanisms underlying arrhythmogenic right ventricular dysplasia/ca$443,439
R01 · FY2011 · HL · contact PI
Enhanced cardiomyocyte differentiation and maturation using myocardial matrix$210,295
R21 · FY2011 · HL
The molecular mechanisms underlying arrhythmogenic right ventricular dysplasia/ca$386,250
R01 · FY2010 · HL · contact PI
Enhanced cardiomyocyte differentiation and maturation using myocardial matrix$185,295
R21 · FY2010 · HL
The molecular mechanisms underlying arrhythmogenic right ventricular dysplasia/ca$33,839
R01 · FY2010 · HL · contact PI
The molecular mechanisms underlying arrhythmogenic right ventricular dysplasia/ca$386,250
R01 · FY2009 · HL · contact PI
The molecular mechanisms underlying arrhythmogenic right ventricular dysplasia/ca$225,202
R01 · FY2009 · HL · contact PI
THE ROLE OF DESMOPLAKIN IN CARDIAC DEVELOPMENT AND DISEASE$9,756
P41 · FY2008 · RR · contact PI
THE ROLE OF DESMOPLAKIN IN CARDIAC DEVELOPMENT AND DISEASE$10,853
P41 · FY2007 · RR · contact PI